Suritozole
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
5-(3-fluorophenyl)-2,4-dimethyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
|
|
Identifiers | |
CAS Number | 110623-33-1 |
ATC code | none |
PubChem | CID: 25431 |
ChemSpider | 23743 |
UNII | 3H7H68317X |
KEGG | D05980 |
Chemical data | |
Formula | C10H10FN3S |
Molecular mass | 223.269 g/mol |
|
|
|
|
(what is this?) (verify) |
Suritozole (MDL 26,479) is an investigational cognition enhancer. It acts as a partial inverse agonist at the benzodiazepine receptor site on the GABAA ion channel complex, but does not have either anxiogenic or convulsant effects, unlike other BZD inverse agonists such as DMCM.[1] It was investigated for the treatment of depression and Alzheimer's disease,[2] but clinical development seems to have been discontinued.
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs not assigned an ATC code
- Drugs with no legal status
- Nootropics
- Organofluorides
- Triazoles
- Organosulfur compounds
- GABAA receptor negative allosteric modulators
- Nervous system drug stubs